{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:43:46Z","timestamp":1789087426183,"version":"build-2803163510"},"reference-count":39,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and\u00a0Objectives: Small airway fibrosis plays a critical role in the progression of chronic obstructive pulmonary disease (COPD). Previous research has suggested that Urotensin-II (U-II) and transforming growth factor-\u03b2 (TGF-\u03b2) may contribute to pathological fibrosis in various organs, including the cardiovascular system, lungs, and liver. However, their specific relationship with airway fibrosis in COPD has not yet been thoroughly investigated. This study aims to evaluate the concentrations of U-II and TGF-\u03b2 in individuals with COPD, as well as in healthy smokers and non-smokers, to explore their potential roles in COPD-related fibrosis. Materials and Methods: The study included three distinct groups: a healthy non-smoker control group (n = 98), a healthy smoker group (n = 78), and a COPD group (n = 80). All participants in the COPD group had a smoking history of at least 10 pack-years. COPD was defined according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, with only patients classified as GOLD stage 2 or higher being included in the study. Urotensin-II (U-II) and transforming growth factor-\u03b2 (TGF-\u03b2) levels were measured using a commercially available ELISA kit. Results: COPD patients had a significantly lower FEV1 (58 \u00b1 15.4%) compared to smokers (79 \u00b1 4.5%) and non-smokers (92 \u00b1 3.7%) (p &lt; 0.001). Similarly, COPD patients had a lower FEV1\/FVC ratio (55 \u00b1 9.4%) compared to smokers (72 \u00b1 4.2%) and non-smokers (85 \u00b1 3.6%) (p &lt; 0.01 and p &lt; 0.05, respectively). SaO2 was significantly lower in COPD patients (87%) compared to smokers (96.5%) and non-smokers (98%) (COPD vs. smokers: p &lt; 0.05 and smokers vs. non-smokers: p &gt; 0.05). U-II levels were significantly higher in COPD patients (175.10 \u00b1 62.40 pg\/mL) compared to smokers (118.50 \u00b1 45.51 pg\/mL) and non-smokers (85.29 \u00b1 35.87 pg\/mL) (p &lt; 0.001 and p &lt; 0.05, respectively). COPD patients also had significantly higher levels of TGF-\u03b2 (284.60 \u00b1 60.50 pg\/mL) compared to smokers (160.00 \u00b1 41.80 pg\/mL) and non-smokers (92.00 \u00b1 25.00 pg\/mL) (p &lt; 0.001 and p &lt; 0.05, respectively). Conclusions: Our study supports the growing body of evidence that U-II and TGF-\u03b2 play central roles in the development and progression of fibrosis in COPD. The negative correlation between these markers and lung function parameters such as FEV1 and FEV1\/FVC indicates that they may be key drivers of airway remodeling and obstruction. These biomarkers could serve as early indicators of fibrotic changes in smokers, even before the onset of COPD.<\/jats:p>","DOI":"10.3390\/medicina60111750","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T09:11:47Z","timestamp":1729761107000},"page":"1750","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevated Urotensin-II and TGF-\u03b2 Levels in COPD: Biomarkers of Fibrosis and Airway Remodeling in Smokers"],"prefix":"10.3390","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-1274","authenticated-orcid":false,"given":"Metin","family":"Kilinc","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Reanimation, Faculty of Medicine, Mardin Artuklu University, Mardin 47200, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Reanimation, Mardin Training and Research Hospital, Mardin 47000, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1087-3070","authenticated-orcid":false,"given":"Semih","family":"Aydemir","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Reanimation, Y\u0131ld\u0131r\u0131m Beyazit University Yenimahalle Training and Research Hospital, Ankara 06370, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rauf","family":"Gul","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Reanimation, School of Medicine, Gaziantep University, Gaziantep 27410, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-3477","authenticated-orcid":false,"given":"Recep","family":"Dokuyucu","sequence":"additional","affiliation":[{"name":"Department of Physiology, Medical Specialization Training Center (TUSMER), Ankara 06420, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.34172\/aim.2021.100","article-title":"Evaluation of Work-Related Symptoms by Job Exposure Matrix in Chronic Pulmonary Diseases\u2014A Cross-sectional Study","volume":"24","author":"Matoori","year":"2021","journal-title":"Arch. Iran. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","article-title":"Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease","volume":"203","author":"Halpin","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.21608\/ejhc.2023.329537","article-title":"Assessment Quality of Life for Patients with Chronic Obstructive Pulmonary Disease in Outpatients Clinic at Beni-Suef University Hospital","volume":"14","author":"Awadeen","year":"2023","journal-title":"Egypt. J. Health Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/jamp.2019.1576","article-title":"Global Burden of Chronic Respiratory Diseases","volume":"33","author":"Viegi","year":"2020","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/15412555.2019.1653271","article-title":"The Comorbidity of Chronic Obstructive Pulmonary Disease and Peripheral Artery Disease\u2014A Systematic Review","volume":"16","author":"Kaszuba","year":"2019","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ntr\/nty077","article-title":"Smoking, Systemic Inflammation, and Airflow Limitation: A Mendelian Randomization Analysis of 98 085 Individuals From the General Population","volume":"21","author":"Colak","year":"2019","journal-title":"Nicotine Tob. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nyas.12714","article-title":"Exploring the link between scavenger receptor B1 expression and chronic obstructive pulmonary disease pathogenesis","volume":"1340","author":"Valacchi","year":"2015","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1165\/rcmb.2018-0261OC","article-title":"Alternative Oxidase Attenuates Cigarette Smoke-induced Lung Dysfunction and Tissue Damage","volume":"60","author":"Giordano","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gene.2018.12.061","article-title":"Associations of the NRF2\/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease","volume":"692","author":"Korytina","year":"2019","journal-title":"Gene"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.chest.2018.12.022","article-title":"Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS","volume":"155","author":"Garudadri","year":"2019","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tanabe, N., Sato, S., Suki, B., and Hirai, T. (2020). Fractal Analysis of Lung Structure in Chronic Obstructive Pulmonary Disease. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.603197"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Poto, R., Loffredo, S., Palestra, F., Marone, G., Patella, V., and Varricchi, G. (2022). Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions. Cells, 11.","DOI":"10.3390\/cells11101720"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1165\/rcmb.2023-0147OC","article-title":"Epigenetic Reprogramming Drives Epithelial Disruption in Chronic Obstructive Pulmonary Disease","volume":"70","author":"Wally","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"L14","DOI":"10.1152\/ajplung.00400.2018","article-title":"TGF-beta activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formation","volume":"317","author":"Kortekaas","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000497415","article-title":"TGF-beta1 Impairs Vitamin D-Induced and Constitutive Airway Epithelial Host Defense Mechanisms","volume":"12","author":"Schrumpf","year":"2020","journal-title":"J. Innate Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/13685538.2018.1501016","article-title":"The relationship between health literacy and disease specific costs in subjects with chronic obstructive pulmonary disease (COPD)","volume":"23","author":"Ture","year":"2020","journal-title":"Aging Male"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.drudis.2019.08.005","article-title":"Novel insights into the role of urotensin II in cardiovascular disease","volume":"24","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.5114\/aoms.2019.85197","article-title":"Urotensin II promotes secretion of LTB(4) through 5-lipoxygenase via the UT-ROS-Akt pathway in RAW264.7 macrophages","volume":"15","author":"Lu","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chen, X., Yin, L., Jia, W.H., Wang, N.Q., Xu, C.Y., Hou, B.Y., Li, N., Zhang, L., Qiang, G.F., and Yang, X.Y. (2019). Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00453"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5483\/BMBRep.2019.52.10.206","article-title":"Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition","volume":"52","author":"Xu","year":"2019","journal-title":"BMB Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1536\/ihj.21-032","article-title":"Urotensin II Induces Cardiac Fibrosis through the TGF-beta\/Smad Signaling Pathway during the Development of Cardiac Hypertrophy","volume":"62","author":"Liang","year":"2021","journal-title":"Int. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s10753-011-9421-6","article-title":"The efficiency of a urotensin II antagonist in an experimental lung fibrosis model","volume":"35","author":"Onat","year":"2012","journal-title":"Inflammation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11010-012-1229-7","article-title":"Urotensin upregulates transforming growth factor-beta1 expression of asthma airway through ERK-dependent pathway","volume":"364","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yilmaz, M., and Dokuyucu, R. (2023). Effects of Thymoquinone on Urotensin-II and TGF-beta1 Levels in Model of Osteonecrosis in Rats. Medicina, 59.","DOI":"10.3390\/medicina59101781"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.regpep.2012.12.006","article-title":"Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-beta1\/Smad2\/3 signaling pathway","volume":"182","author":"Zhao","year":"2013","journal-title":"Regul. Pept."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.peptides.2014.01.010","article-title":"Urotensin II (U-II), a novel cyclic peptide, possibly associated with the pathophysiology of osteoarthritis","volume":"54","author":"Gogebakan","year":"2014","journal-title":"Peptides"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary","volume":"207","author":"Agusti","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"L111","DOI":"10.1152\/ajplung.00155.2023","article-title":"Anoctamin-1 is induced by TGF-beta and contributes to lung myofibroblast differentiation","volume":"326","author":"Reed","year":"2024","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, C., Lu, J., Yuan, T., Xie, L., and Zhang, L. (2023). EPC-exosomal miR-26a-5p improves airway remodeling in COPD by inhibiting ferroptosis of bronchial epithelial cells via PTGS2\/PGE2 signaling pathway. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-33151-w"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/08977194.2023.2239356","article-title":"Role of transforming growth factor-\u03b2 in airway remodelling in bronchiolitis obliterans","volume":"41","author":"Wang","year":"2023","journal-title":"Growth Factors"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Di Stefano, A., Rosani, U., Levra, S., Gnemmi, I., Brun, P., Maniscalco, M., D\u2019Anna, S.E., Carriero, V., Bertolini, F., and Ricciardolo, F.L.M. (2023). Bone Morphogenic Proteins and Their Antagonists in the Lower Airways of Stable COPD Patients. Biology, 12.","DOI":"10.3390\/biology12101304"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kraik, K., Tota, M., Laska, J., Lacwik, J., Pazdzierz, L., Sedek, L., and Gomulka, K. (2024). The Role of Transforming Growth Factor-beta (TGF-beta) in Asthma and Chronic Obstructive Pulmonary Disease (COPD). Cells, 13.","DOI":"10.3390\/cells13151271"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Xie, S., Macedo, P., Hew, M., Nassenstein, C., Lee, K.-Y., and Chung, K.F. (2009). Expression of transforming growth factor-\u03b2 (TGF-\u03b2) in chronic idiopathic cough. Respir. Res., 10.","DOI":"10.1186\/1465-9921-10-40"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"L173","DOI":"10.1152\/ajplung.00022.2024","article-title":"A comprehensive map of proteoglycan expression and deposition in the pulmonary arterial wall in health and pulmonary hypertension","volume":"327","author":"Mutgan","year":"2024","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ding, L., Qi, H., Wang, Y., Zhang, Z., Liu, Q., Guo, C., Liu, J., Chen, Z., Li, J., and Chen, J. (2023). Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms. Biomed. Pharmacother., 158.","DOI":"10.1016\/j.biopha.2022.114096"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.resp.2012.03.009","article-title":"The message in the air: Hydrogen sulfide metabolism in chronic respiratory diseases","volume":"184","author":"Chen","year":"2012","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.fct.2017.06.016","article-title":"Silibinin inhibits the fibrotic responses induced by cigarette smoke via suppression of TGF-\u03b21\/Smad 2\/3 signaling","volume":"106","author":"Ko","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11684-019-0689-5","article-title":"Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl(4)-induced cirrhotic rats","volume":"13","author":"Zhang","year":"2019","journal-title":"Front. Med."},{"key":"ref_39","first-page":"1","article-title":"Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis via the TGF-\u03b21\/SMAD3 Pathway In Vivo and In vitro","volume":"11","author":"Wang","year":"2022","journal-title":"J. Clin. Transl. Hepatol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1750\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:19:39Z","timestamp":1760113179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["medicina60111750"],"URL":"https:\/\/doi.org\/10.3390\/medicina60111750","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}